Novel low‐avidity glypican‐3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC

Corresponding Author

Yukai He

Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, Georgia, USA

Department of Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia, USA

Correspondence

Yukai He, CN-4150, Georgia Cancer Center, Medical College of Georgia, Augusta University, 1410 Laney Walker Blvd, Augusta, GA 30912, USA.

Email: yhe@augusta.edu

Search for more papers by this author

留言 (0)

沒有登入
gif